T2	GGPs 420 429	TNF-alpha
T4	Disorder 552 555	IPF
T6	Cell 968 980	immune cells
T7	Disorder 146 157	sarcoidosis
T11	GGPs 40 50	chemokines
T15	GGPs 1205 1214	TNF-alpha
T16	Method_cue 618 623	ELISA
T18	Subject 996 1004	patients
T20	GGPs 1531 1542	MIP-1 alpha
T22	GGPs 663 672	cytokines
T26	Disorder 992 995	SAR
T27	GGPs 901 912	MIP-1 alpha
T28	Cell 77 82	cells
T29	Subject 1639 1647	patients
T30	Disorder 521 550	idiopathic pulmonary fibrosis
T31	Subject 1109 1117	patients
T32	Disorder 1448 1451	SAR
T34	GGPs 303 314	MIP-1 alpha
T35	Disorder 566 577	sarcoidosis
T38	Gene_expression 1983 1993	expression
T41	GGPs 437 448	MIP-1 alpha
T42	Negation_cue 1576 1579	not
T44	GGPs 1713 1724	MIP-1 alpha
T46	Subject 86 94	patients
T47	Cell 1563 1575	immune cells
T49	Disorder 1334 1337	SAR
T50	Disorder 2072 2075	IPF
T53	Disorder 1073 1081	diseases
T54	GGPs 237 250	interleukin-8
T55	GGPs 1997 2006	TNF-alpha
T57	Disorder 112 141	idiopathic pulmonary fibrosis
T58	Disorder 1440 1443	IPF
T61	Disorder 579 582	SAR
T62	Cell 680 685	cells
T63	Disorder 1801 1804	SAR
T66	Disorder 767 774	disease
T68	GGPs 1226 1237	MIP-1 alpha
T70	GGPs 252 256	IL-8
T71	Disorder 1139 1142	IPF
T73	Subject 1338 1346	patients
T75	GGPs 891 895	IL-8
T77	Subject 2084 2092	patients
T81	GGPs 880 889	TNF-alpha
T86	Disorder 1276 1279	IPF
T87	Subject 798 806	patients
T90	Disorder 2080 2083	SAR
T91	Subject 1452 1460	patients
T92	Disorder 1793 1796	IPF
T97	GGPs 1510 1519	TNF-alpha
T98	Cell 491 503	immune cells
T99	Subject 1894 1902	subgroup
T107	Cell 2044 2049	cells
T109	Disorder 352 378	interstitial lung diseases
T110	GGPs 1495 1499	mRNA
T113	Gene_expression 10 20	expression
T115	Disorder 984 987	IPF
T116	GGPs 1216 1220	IL-8
T117	Subject 1280 1288	patients
T121	GGPs 226 236	chemokines
T122	Gene_expression 638 653	mRNA expression
T123	Disorder 1890 1893	IPF
T124	Disorder 1157 1160	SAR
T126	GGPs 2018 2029	MIP-1 alpha
T127	Anatomical_entity 1774 1777	BAL
E5	Gene_expression:T38 Theme:T126
E13	Gene_expression:T113 Theme:T11 atLoc:T28
E14	Gene_expression:T122 Theme:T22 atLoc:T62
N7	Reference T2 UMLS:C1456820	Tumor Necrosis Factor-alpha
N15	Reference T4 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N20	Reference T6 UMLS:C0007634	Cells
N23	Reference T7 UMLS:C0036202	Sarcoidosis
N53	Reference T15 UMLS:C1456820	Tumor Necrosis Factor-alpha
N56	Reference T16 UMLS:C0014441	Enzyme-Linked Immunosorbent Assay
N59	Reference T18 UMLS:C0030705	Patients
N95	Reference T28 UMLS:C0007634	Cells
N96	Reference T29 UMLS:C0030705	Patients
N98	Reference T30 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N101	Reference T31 UMLS:C0030705	Patients
N112	Reference T35 UMLS:C0036202	Sarcoidosis
N149	Reference T46 UMLS:C0030705	Patients
N159	Reference T50 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N171	Reference T53 UMLS:C0012634	Disease
N177	Reference T54 UMLS:C0079633	Interleukin-8
N183	Reference T55 UMLS:C1456820	Tumor Necrosis Factor-alpha
N190	Reference T57 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N194	Reference T58 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N207	Reference T62 UMLS:C0007634	Cells
N217	Reference T66 UMLS:C0012634	Disease
N232	Reference T71 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N237	Reference T73 UMLS:C0030705	Patients
N247	Reference T77 UMLS:C0030705	Patients
N263	Reference T81 UMLS:C1456820	Tumor Necrosis Factor-alpha
N277	Reference T86 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N280	Reference T87 UMLS:C0030705	Patients
N288	Reference T91 UMLS:C0030705	Patients
N291	Reference T92 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N313	Reference T99 UMLS:C1515021	Subgroup
N338	Reference T107 UMLS:C0007634	Cells
N342	Reference T109 UMLS:C0206062	Lung Diseases, Interstitial
N345	Reference T110 UMLS:C0035696	RNA, Messenger
N360	Reference T115 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N365	Reference T117 UMLS:C0030705	Patients
N375	Reference T121 UMLS:C0282554	chemokine
N379	Reference T123 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N13	Reference T61 UMLS:C0036202	Sarcoidosis
N14	Reference T26 UMLS:C0036202	Sarcoidosis
N16	Reference T124 UMLS:C0036202	Sarcoidosis
N17	Reference T49 UMLS:C0036202	Sarcoidosis
N19	Reference T32 UMLS:C0036202	Sarcoidosis
N22	Reference T63 UMLS:C0036202	Sarcoidosis
N24	Reference T90 UMLS:C0036202	Sarcoidosis
N29	Reference T34 UMLS:C0128546	Small Inducible Cytokine A3
N31	Reference T41 UMLS:C0128546	Small Inducible Cytokine A3
N32	Reference T27 UMLS:C0128546	Small Inducible Cytokine A3
N33	Reference T68 UMLS:C0128546	Small Inducible Cytokine A3
N34	Reference T44 UMLS:C0128546	Small Inducible Cytokine A3
N35	Reference T126 UMLS:C0128546	Small Inducible Cytokine A3
N37	Reference T70 UMLS:C0079633	Interleukin-8
T14	GGPs 431 435	IL-8
N39	Reference T14 UMLS:C0079633	Interleukin-8
N40	Reference T75 UMLS:C0079633	Interleukin-8
N44	Reference T116 UMLS:C0079633	Interleukin-8
T33	GGPs 1521 1525	IL-8
T67	GGPs 2008 2012	IL-8
N48	Reference T67 UMLS:C0079633	Interleukin-8
T72	GGPs 262 301	macrophage inflammatory protein-1 alpha
N6	Reference T72 UMLS:C0128546	Small Inducible Cytokine A3
N49	Reference T97 UMLS:C0812246	TNF gene
N45	Reference T33 UMLS:C1366571	CXCL8 gene
N28	Reference T20 UMLS:C1332690	CCL3 gene
T56	Anatomical_entity 948 960	supernatants
N50	Reference T56 UMLS:C1550101	Supernatant
T59	Subject 828 834	groups
N51	Reference T59 UMLS:C1257890	Population Group
T89	Subject 1452 1460	patients
N54	Reference T89 UMLS:C0030705	Patients
T93	Subject 2084 2092	patients
N55	Reference T93 UMLS:C0030705	Patients
T95	Subject 597 605	controls
N58	Reference T95 UMLS:C0009932	Control Groups
T100	Subject 1042 1050	controls
N60	Reference T100 UMLS:C0009932	Control Groups
T104	Subject 1313 1321	controls
N61	Reference T104 UMLS:C0009932	Control Groups
T105	Subject 1671 1679	controls
N64	Reference T105 UMLS:C0009932	Control Groups
T133	Subject 507 515	patients
N65	Reference T133 UMLS:C0030705	Patients
T134	Subject 557 563	n = 24
N66	Reference T134 UMLS:C0030705	Patients
T135	Subject 584 590	n = 24
N67	Reference T135 UMLS:C0030705	Patients
T137	Subject 996 1004	patients
N71	Reference T137 UMLS:C0030705	Patients
T136	Subject 86 94	patients
N69	Reference T136 UMLS:C0030705	Patients
R3	Subject_Disorder Arg1:T136 Arg2:T57	
R4	Subject_Disorder Arg1:T46 Arg2:T7	
R8	Subject_Disorder Arg1:T137 Arg2:T115	
R9	Subject_Disorder Arg1:T18 Arg2:T26	
R12	Subject_Disorder Arg1:T117 Arg2:T86	
R13	Subject_Disorder Arg1:T73 Arg2:T49	
R14	Subject_Disorder Arg1:T89 Arg2:T58	
R15	Subject_Disorder Arg1:T91 Arg2:T32	
R18	Subject_Disorder Arg1:T99 Arg2:T123	
R20	Subject_Disorder Arg1:T93 Arg2:T50	
R21	Subject_Disorder Arg1:T77 Arg2:T90	
R1	member_of Arg1:T134 Arg2:T133	
R2	member_of Arg1:T135 Arg2:T133	
R5	Subject_Disorder Arg1:T134 Arg2:T30	
R6	Subject_Disorder Arg1:T135 Arg2:T35	
N38	Reference E14 UMLS:C0040649	Transcription, Genetic
N70	Reference T22 UMLS:C1333196	Cytokine Gene
N72	Reference E13 UMLS:C0017262	Gene Expression
N73	Reference E5 UMLS:C0017262	Gene Expression
E9	Gene_expression:T38 Theme:T67
N74	Reference E9 UMLS:C0017262	Gene Expression
E10	Gene_expression:T38 Theme:T55
N75	Reference E10 UMLS:C0017262	Gene Expression
T12	Anatomical_entity 54 76	bronchoalveolar lavage
N78	Reference T12 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T19	Anatomical_entity 462 484	bronchoalveolar lavage
N62	Reference T19 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T138	Anatomical_entity 486 489	BAL
N63	Reference T138 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T108	Anatomical_entity 676 679	BAL
N80	Reference T108 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T119	Anatomical_entity 964 967	BAL
N83	Reference T119 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T139	Anatomical_entity 1559 1562	BAL
N84	Reference T139 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T141	Anatomical_entity 1852 1855	BAL
N88	Reference T141 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T142	Anatomical_entity 2033 2036	BAL
N89	Reference T142 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N30	Reference T127 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T9	Positive_regulation 1874 1882	elevated
E3	Positive_regulation:T9 disorder:T123 Theme:T25
N57	Reference E3 UMLS:C1879547	Activation action
T17	Positive_regulation 932 940	elevated
E12	Positive_regulation:T17 Theme:T27 disorder:T26 atLoc:T56
N87	Reference E12 UMLS:C1879547	Activation action
T36	Positive_regulation 0 9	Increased
E15	Positive_regulation:T36 Theme:E13 disorder:T7
N90	Reference E15 UMLS:C1879547	Activation action
T48	Positive_regulation 1592 1602	stimulated
E16	Positive_regulation:T48 Cause:E2 Cue:T42 Theme:T47
N91	Reference E16 UMLS:C1879547	Activation action
A1	Count_sbjct T134
A2	Count_sbjct T135
T1	Subject 607 613	n = 20
N1	Reference T1 UMLS:C0009932	Control Groups
A3	Count_sbjct T1
R24	member_of Arg1:T1 Arg2:T95	
T65	Biological_process 336 348	pathogenesis
E17	Biological_process:T65 Theme:T109
N2	Reference E17 UMLS:C0699748	Pathogenesis
E18	Positive_regulation:T36 Theme:E19 disorder:T57
N3	Reference E18 UMLS:C1879547	Activation action
E19	Gene_expression:T113 Theme:T11 atLoc:T28
N92	Reference E19 UMLS:C0017262	Gene Expression
R25	part_of Arg1:T28 Arg2:T12	
T69	Localization 409 416	release
E20	Localization:T69 Theme:T41 fromLoc:T98 Cue:T43 Cue2:T16
N93	Reference E20 UMLS:C0036536	Process of secretion
E21	Positive_regulation:T17 Theme:T27 disorder:T115 atLoc:T56
N94	Reference E21 UMLS:C1879547	Activation action
E22	Positive_regulation:T17 Theme:T75 disorder:T26 atLoc:T56
N97	Reference E22 UMLS:C1879547	Activation action
E23	Positive_regulation:T17 Theme:T75 atLoc:T56 disorder:T115
N99	Reference E23 UMLS:C1879547	Activation action
E24	Positive_regulation:T17 Theme:T81 disorder:T26 atLoc:T56
N100	Reference E24 UMLS:C1879547	Activation action
E25	Positive_regulation:T17 Theme:T81 atLoc:T56 disorder:T115
N102	Reference E25 UMLS:C1879547	Activation action
R31	part_of Arg1:T56 Arg2:T119	
T83	Localization 1194 1201	release
E26	Localization:T83 Theme:T68
N103	Reference E26 UMLS:C0036536	Process of secretion
T128	Localization 1725 1732	release
E27	Localization:T128 Theme:T44
N104	Reference E27 UMLS:C0036536	Process of secretion
T106	Correlation 320 328	involved
E11	Correlation:T106 Theme:T54 Theme2:T72 Theme3:E17
T13	Cellular_process 1606 1615	adherence
E2	Cellular_process:T13 
N41	Reference E2 UMLS:C0007577	Cell Adhesion
E4	Localization:T69 Theme:T14 fromLoc:T98 Cue:T43 Cue2:T16
N42	Reference E4 UMLS:C0036536	Process of secretion
E6	Localization:T69 Theme:T2 fromLoc:T98 Cue:T43 Cue2:T16
N43	Reference E6 UMLS:C0036536	Process of secretion
R32	part_of Arg1:T98 Arg2:T138	
E28	Localization:T83 Theme:T116
N46	Reference E28 UMLS:C0036536	Process of secretion
E29	Localization:T83 Theme:T15
N47	Reference E29 UMLS:C0036536	Process of secretion
R33	part_of Arg1:T62 Arg2:T108	
A4	Negated E16
T52	Entity_Property 840 851	progressing
N11	Reference T52 UMLS:C0205329	Progressive
T64	Entity_Property 1010 1021	progressing
N26	Reference T64 UMLS:C0205329	Progressive
T79	Entity_Property 1466 1477	progressing
N27	Reference T79 UMLS:C0205329	Progressive
T101	Entity_Property 1908 1919	progressing
N81	Reference T101 UMLS:C0205329	Progressive
T111	Entity_Property 2102 2113	progressing
N82	Reference T111 UMLS:C0205329	Progressive
T140	Entity_Property 1123 1129	stable
N85	Reference T140 UMLS:C0205360	Stable status
T143	Entity_Property 855 861	stable
N86	Reference T143 UMLS:C0205360	Stable status
T144	Entity_Property 1294 1300	stable
N106	Reference T144 UMLS:C0205360	Stable status
T145	Entity_Property 1352 1358	stable
N107	Reference T145 UMLS:C0205360	Stable status
T146	Entity_Property 1653 1659	stable
N108	Reference T146 UMLS:C0205360	Stable status
N4	Reference E11 UMLS:C0332281	Associated with
T37	Artificial_process 452 460	cultured
E1	Artificial_process:T37 Theme:T98
R7	member_of Arg1:T54 Arg2:T121	
R10	member_of Arg1:T72 Arg2:T121	
T25	Measurement 1823 1848	percentage of eosinophils
N8	Reference T25 UMLS:C1171399	Eosinophil percentage measurement
T74	Positive_regulation 1971 1982	exaggerated
E8	Positive_regulation:T74 Theme:E10 Cue:T3
N25	Reference E8 UMLS:C1879547	Activation action
E30	Positive_regulation:T74 Theme:E5 Cue:T3
N79	Reference E30 UMLS:C1879547	Activation action
E31	Positive_regulation:T74 Theme:E9 Cue:T3
N105	Reference E31 UMLS:C1879547	Activation action
T51	Correlation 2053 2067	characteristic
E32	Correlation:T51 Theme:E8 Theme2:E30 Theme3:E31 Theme4:T90
N109	Reference E32 UMLS:C0332281	Associated with
E33	Correlation:T51 Theme:E8 Theme2:E30 Theme3:E31 Theme4:T50
N110	Reference E33 UMLS:C0332281	Associated with
T39	Measurement 1760 1770;1778 1789	percentage eosinophils
N12	Reference T39 UMLS:C1171399	Eosinophil percentage measurement
N5	Reference E1 UMLS:C1449619	Culture Techniques
N9	Reference T11 UMLS:C0282554	chemokine
T8	Disorder 862 869	disease
N21	Reference T8 UMLS:C0012634	Disease
T10	Disorder 1022 1029	disease
N36	Reference T10 UMLS:C0012634	Disease
T78	Disorder 1130 1137	disease
N111	Reference T78 UMLS:C0012634	Disease
T80	Disorder 1301 1308	disease
N113	Reference T80 UMLS:C0012634	Disease
T94	Disorder 1359 1366	disease
N114	Reference T94 UMLS:C0012634	Disease
T96	Disorder 1660 1667	disease
N115	Reference T96 UMLS:C0012634	Disease
T103	Disorder 1920 1927	disease
N116	Reference T103 UMLS:C0012634	Disease
T125	Disorder 2114 2121	disease
N117	Reference T125 UMLS:C0012634	Disease
T129	Artificial_process 711 723	bronchoscopy
E7	Artificial_process:T129 
N118	Reference E7 UMLS:C0006290	Bronchoscopy
A5	Speculated E11
T43	Speculation_cue 392 404	investigated
R11	part_of Arg1:T19 Arg2:T133	
R16	part_of Arg1:T19 Arg2:T134	
R17	part_of Arg1:T19 Arg2:T135	
R19	part_of Arg1:T19 Arg2:T95	
A6	Speculated E20
A7	Speculated E6
A8	Speculated E4
T76	Disorder 1478 1485	disease
N18	Reference T76 UMLS:C0012634	Disease
T118	Correlation 1733 1743	correlated
E34	Correlation:T118 Theme:E27 Theme2:T39 disorder:T92
N119	Reference E34 UMLS:C0332281	Associated with
E35	Correlation:T118 Theme:E27 Theme2:T39 disorder:T63
N10	Reference E35 UMLS:C0332281	Associated with
T3	Speculation_cue 1951 1962	demonstrate
A9	Speculated E30
A10	Speculated E31
A11	Speculated E8
N52	Reference T98 UMLS:C0007634	Cells
N120	Reference T47 UMLS:C0007634	Cells
T5	Method_cue 711 723	bronchoscopy
N121	Reference T5 UMLS:C0006290	Bronchoscopy
